231 related articles for article (PubMed ID: 34424811)
21. Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.
Nachef M; Ali AK; Almutairi SM; Lee SH
Front Immunol; 2021; 12():624324. PubMed ID: 33953707
[TBL] [Abstract][Full Text] [Related]
22. Monocarboxylate transporters: past, present, and future.
Merezhinskaya N; Fishbein WN
Histol Histopathol; 2009 Feb; 24(2):243-64. PubMed ID: 19085840
[TBL] [Abstract][Full Text] [Related]
23. The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment.
Hayes C; Donohoe CL; Davern M; Donlon NE
Cancer Lett; 2021 Mar; 500():75-86. PubMed ID: 33347908
[TBL] [Abstract][Full Text] [Related]
24. Tissue distribution and thyroid hormone effects on mRNA abundance for membrane transporters Mct8, Mct10, and organic anion-transporting polypeptides (Oatps) in a teleost fish.
Muzzio AM; Noyes PD; Stapleton HM; Lema SC
Comp Biochem Physiol A Mol Integr Physiol; 2014 Jan; 167():77-89. PubMed ID: 24113777
[TBL] [Abstract][Full Text] [Related]
25. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Mo Z; Li P; Cao Z; Zhang S
Front Immunol; 2021; 12():564948. PubMed ID: 34290693
[TBL] [Abstract][Full Text] [Related]
26. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
Marchiq I; Pouysségur J
J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
[TBL] [Abstract][Full Text] [Related]
28. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
[TBL] [Abstract][Full Text] [Related]
29. Lactic acid promotes macrophage polarization through MCT-HIF1α signaling in gastric cancer.
Zhang L; Li S
Exp Cell Res; 2020 Mar; 388(2):111846. PubMed ID: 31945319
[TBL] [Abstract][Full Text] [Related]
30. CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance.
Afonso J; Santos LL; Miranda-Gonçalves V; Morais A; Amaro T; Longatto-Filho A; Baltazar F
Mol Carcinog; 2015 Nov; 54(11):1451-66. PubMed ID: 25263481
[TBL] [Abstract][Full Text] [Related]
31. Database mining analysis revealed the role of the putative H
Xie J; Ruan S; Zhu Z; Wang M; Cao Y; Ou M; Yu P; Shi J
Channels (Austin); 2021 Dec; 15(1):496-506. PubMed ID: 34334114
[TBL] [Abstract][Full Text] [Related]
32. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.
Englund G; Rorsman F; Rönnblom A; Karlbom U; Lazorova L; Gråsjö J; Kindmark A; Artursson P
Eur J Pharm Sci; 2006 Nov; 29(3-4):269-77. PubMed ID: 16822659
[TBL] [Abstract][Full Text] [Related]
33. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment.
Li N; Kang Y; Wang L; Huff S; Tang R; Hui H; Agrawal K; Gonzalez GM; Wang Y; Patel SP; Rana TM
Proc Natl Acad Sci U S A; 2020 Aug; 117(33):20159-20170. PubMed ID: 32747553
[TBL] [Abstract][Full Text] [Related]
34. The metabolic microenvironment of melanomas: Prognostic value of MCT1 and MCT4.
Pinheiro C; Miranda-Gonçalves V; Longatto-Filho A; Vicente AL; Berardinelli GN; Scapulatempo-Neto C; Costa RF; Viana CR; Reis RM; Baltazar F; Vazquez VL
Cell Cycle; 2016 Jun; 15(11):1462-70. PubMed ID: 27105345
[TBL] [Abstract][Full Text] [Related]
35. Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies.
Pérez-Ruiz E; Melero I; Kopecka J; Sarmento-Ribeiro AB; García-Aranda M; De Las Rivas J
Drug Resist Updat; 2020 Dec; 53():100718. PubMed ID: 32736034
[TBL] [Abstract][Full Text] [Related]
36. The loop between helix 4 and helix 5 in the monocarboxylate transporter MCT1 is important for substrate selection and protein stability.
Galić S; Schneider HP; Bröer A; Deitmer JW; Bröer S
Biochem J; 2003 Dec; 376(Pt 2):413-22. PubMed ID: 12946269
[TBL] [Abstract][Full Text] [Related]
37. Expression and cellular localization of monocarboxylate transporters (MCT2, MCT7, and MCT8) along the cattle gastrointestinal tract.
Kirat D; Sallam KI; Kato S
Cell Tissue Res; 2013 Jun; 352(3):585-98. PubMed ID: 23417128
[TBL] [Abstract][Full Text] [Related]
38. The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters.
Li X; Yu X; Dai D; Song X; Xu W
Oncotarget; 2016 Apr; 7(17):23141-55. PubMed ID: 27009812
[TBL] [Abstract][Full Text] [Related]
39. Monocarboxylate Transporter-2 Expression Restricts Tumor Growth in a Murine Model of Lung Cancer: A Multi-Omic Analysis.
Khalyfa A; Qiao Z; Raju M; Shyu CR; Coghill L; Ericsson A; Gozal D
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638954
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics.
Yu S; Wu Y; Li C; Qu Z; Lou G; Guo X; Ji J; Li N; Guo M; Zhang M; Lei L; Tai S
Sci Rep; 2020 Apr; 10(1):7315. PubMed ID: 32355273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
